Sun Pharmaceutical, India’s largest drug maker by revenue, has agreed to acquire US-listed Organon, which has a portfolio of therapies and products in women’s health, biosimilars and established medicines, for an enterprise value of $11.7 billion. This marks the largest overseas acquisition by an Indian pharmaceutical company to date.
April 30, 2026